Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
TTOO - T2 Biosystems Inc - Stock Price Chart
TickerTTOO [NASD]
CompanyT2 Biosystems Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap16.53MEPS (ttm)-145.61
P/E-EPS this Y74.36%
Forward P/E-EPS next Y76.01%
PEG-EPS past 5Y68.62%
P/S2.30EPS next 5Y-
P/B-EPS Q/Q98.19%
Dividend-Sales Q/Q-69.38%
Insider Own97.87%Inst Own3.96%
Insider Trans0.00%Inst Trans23.05%
Short Float312.07%EarningsMay 06/a
Analyst Recom3.00Target Price3.50
Avg Volume296.01K52W Range2.60 - 70.00
Apr-24-24 09:00AM T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 (GlobeNewswire)
Apr-23-24 07:39AM Top Premarket Decliners (MT Newswires) -13.92%
Apr-11-24 04:05PM T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity (GlobeNewswire)
Mar-28-24 09:00AM T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. (GlobeNewswire)
Mar-20-24 07:30AM T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates (GlobeNewswire) -10.89%
Mar-19-24 09:00AM T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates (GlobeNewswire) -11.20%
Mar-18-24 09:00AM T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel (GlobeNewswire) -5.98%
Mar-12-24 03:16PM TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance (InvestorPlace)
09:00AM T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement (GlobeNewswire)
Feb-16-24 09:29AM T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.71%
TROO - TROOPS Inc - Stock Price Chart
TickerTROO [NASD]
CompanyTROOPS Inc
CountryHong Kong
IndustrySoftware - Application
Market Cap130.05MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y67.84%
P/S-EPS next 5Y-
P/B-EPS Q/Q111.53%
Dividend-Sales Q/Q-18.71%
Insider Own53.41%Inst Own0.12%
Insider Trans0.00%Inst Trans-39.02%
Short Float0.49%Earnings-
Analyst Recom-Target Price-
Avg Volume188.54K52W Range1.04 - 4.99
Jul-30-22 10:29AM What Kind Of Shareholders Hold The Majority In TROOPS, Inc.'s (NASDAQ:TROO) Shares? (Simply Wall St.)
Feb-23-22 09:38AM Those who invested in TROOPS (NASDAQ:TROO) three years ago are up 314% (Simply Wall St.) -13.14%
Nov-25-21 09:06AM Is TROOPS, Inc.'s (NASDAQ:TROO) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Nov-22-21 04:30PM TROOPS, INC. Announces 2021 Unaudited Interim Financial Results (PR Newswire)
Nov-16-21 04:30PM TROOPS, Inc. Announces Changes of its Corporate Name and its Trading Symbol (PR Newswire) -12.26%
CUE - Cue Biopharma Inc - Stock Price Chart
TickerCUE [NASD, RUT]
CompanyCue Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap92.66MEPS (ttm)-1.11
P/E-EPS this Y7.03%
Forward P/E-EPS next Y2.71%
PEG-EPS past 5Y10.55%
P/S16.88EPS next 5Y-
P/B2.43EPS Q/Q23.49%
Dividend-Sales Q/Q1104.15%
Insider Own3.24%Inst Own32.78%
Insider Trans0.00%Inst Trans-6.78%
Short Float10.15%EarningsApr 08/a
Analyst Recom1.00Target Price9.40
Avg Volume277.63K52W Range1.30 - 5.12
Apr-25-24 09:35AM Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks (Zacks)
Apr-24-24 10:01AM Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -5.33%
Apr-15-24 09:55AM Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now (Zacks) -8.86%
Apr-09-24 07:36AM Q4 2023 Cue Biopharma Inc Earnings Call (Thomson Reuters StreetEvents) -6.86%
03:02AM Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ... (GuruFocus.com)
Apr-08-24 04:05PM Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights (GlobeNewswire) +10.27%
Apr-02-24 01:53PM CUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:00AM Cue Biopharma to Host Business Update Call and Webcast (GlobeNewswire)
Feb-29-24 10:00AM Cue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium (GlobeNewswire)
Feb-06-24 08:00AM Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire) +5.46%
DSP - Viant Technology Inc - Stock Price Chart
TickerDSP [NASD, RUT]
CompanyViant Technology Inc
CountryUSA
IndustrySoftware - Application
Market Cap128.86MEPS (ttm)-0.24
P/E-EPS this Y137.75%
Forward P/E74.48EPS next Y25.74%
PEG-EPS past 5Y12.19%
P/S0.58EPS next 5Y-
P/B1.88EPS Q/Q124.59%
Dividend-Sales Q/Q18.16%
Insider Own11.90%Inst Own45.20%
Insider Trans0.00%Inst Trans-2.31%
Short Float4.23%EarningsApr 30/a
Analyst Recom1.50Target Price12.17
Avg Volume147.00K52W Range3.75 - 11.63
Today 10:34AM Viant Technology Inc. (NASDAQ:DSP) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.51%
Apr-30-24 09:56PM DSP Stock Earnings: Viant Technology Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:59PM Viant Technology Inc (DSP) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth (GuruFocus.com)
04:43PM Viant: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM Viant Technology Announces First Quarter 2024 Financial Results; Board of Directors Authorizes $50 Million Stock Repurchase Program (Business Wire)
06:00AM Speculative Standouts: 7 Strong Buy' Stocks to Snag for Under $20 (InvestorPlace)
Apr-23-24 03:56PM 3 Stocks That Will Shine in the Coming Economic Recovery (InvestorPlace)
Apr-19-24 07:13AM 7 Stocks Under $15 Predicted to Boom in the Next 2 Years (InvestorPlace)
Apr-17-24 09:40AM Is Viant Technology (DSP) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Apr-16-24 08:00AM Viant Announces Date of First Quarter 2024Financial Results and Conference Call (Business Wire)
LEG - Leggett & Platt, Inc. - Stock Price Chart
TickerLEG [NYSE]
CompanyLeggett & Platt, Inc.
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap1.77BEPS (ttm)-1.00
P/E-EPS this Y-18.35%
Forward P/E10.86EPS next Y7.49%
PEG-EPS past 5Y-
P/S0.37EPS next 5Y5.20%
P/B1.33EPS Q/Q-661.34%
Dividend13.89%Sales Q/Q-6.84%
Insider Own1.95%Inst Own65.44%
Insider Trans0.00%Inst Trans-3.07%
Short Float6.64%EarningsApr 30/a
Analyst Recom3.40Target Price16.75
Avg Volume1.73M52W Range17.19 - 33.50
Today 02:25PM These Dividend Aristocrats Are Slashing Payouts, Ending Decades Of Consecutive Dividend Increases (Benzinga) -26.67%
12:09PM Why Leggett & Platt (LEG) Shares Are Trading Lower Today (StockStory)
11:04AM Leggett (LEG) Lags on Q1 Earnings & Sales, Cuts Dividend by 89% (Zacks)
07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Apr-30-24 08:55PM LEG Stock Earnings: Leggett & Platt Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:11PM Leggett & Platt Inc (LEG) Q1 Earnings: Aligns with EPS Projections Amid Restructuring Efforts (GuruFocus.com)
05:07PM Leggett & Platt (NYSE:LEG) Misses Q1 Revenue Estimates, Stock Drops (StockStory)
04:55PM Legget & Platt: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM LEGGETT & PLATT REPORTS 1Q RESULTS, ANNOUNCES 2Q DIVIDEND OF $.05 AND UPDATES CAPITAL ALLOCATION PRIORITIES (PR Newswire)
Apr-29-24 09:16AM Gear Up for Legget & Platt (LEG) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
AGBA - AGBA Group Holding Limited - Stock Price Chart
TickerAGBA [NASD]
CompanyAGBA Group Holding Limited
CountryHong Kong
IndustryCapital Markets
Market Cap232.10MEPS (ttm)-0.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-332.18%
P/S4.28EPS next 5Y-
P/B26.44EPS Q/Q-322.41%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own0.04%
Insider Trans-Inst Trans0.47%
Short Float0.03%EarningsNov 14/b
Analyst Recom-Target Price-
Avg Volume10.81M52W Range0.32 - 4.29
Apr-30-24 12:45PM AGBA Stock Pops 35% on Triller Merger Update (InvestorPlace) +20.43%
09:00AM Building a Digital Economy Titan: AGBA and Triller Combine in $4 Billion Merger (GlobeNewswire)
Apr-25-24 04:15PM AGBA Stands Firm: The AGBA-Triller Merger is Value-Enhancing to All Stakeholders (GlobeNewswire) -8.57%
Apr-22-24 10:57AM BestGrowthStocks.com Unveils In-Depth Review of Triller Merger with AGBA Group Holding Limited (News Direct) +100.00%
Apr-19-24 08:32AM AGBA/TRILLER $4 billion MERGER: ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS - IMMEDIATELY AND FOR THE LONG TERM (GlobeNewswire) +21.36%
Apr-18-24 08:00AM AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a Game-Changing Power in Digital Content and Financial Services (GlobeNewswire) +157.50%
Mar-28-24 04:10PM AGBA Announces Fourth Quarter 2023 Earnings, Amid Challenging Macro Environment. (GlobeNewswire)
Mar-06-24 07:00AM Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now (GlobeNewswire)
Mar-05-24 07:00AM Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now (GlobeNewswire)
05:00AM Asian Financial Services Stocks Could Soar As Economic Tailwinds Intensify (News Direct)
IHT - Innsuites Hospitality Trust - Stock Price Chart
TickerIHT [AMEX]
CompanyInnsuites Hospitality Trust
CountryUSA
IndustryREIT - Hotel & Motel
Market Cap12.29MEPS (ttm)0.02
P/E55.83EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.64EPS next 5Y-
P/B1.94EPS Q/Q-162.72%
Dividend1.47%Sales Q/Q7.90%
Insider Own73.72%Inst Own2.45%
Insider Trans0.16%Inst Trans1.76%
Short Float0.66%Earnings-
Analyst Recom-Target Price-
Avg Volume4.90K52W Range0.95 - 3.82
Apr-26-24 02:25AM Chairman James Wirth Acquires Shares of InnSuites Hospitality Trust (IHT) (GuruFocus.com)
Apr-19-24 05:25PM IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION (GlobeNewswire) +6.25%
Apr-08-24 06:52AM IHT HOTEL REVENUE CONTINUES TO GROW (GlobeNewswire)
Feb-29-24 01:06PM Chairman James Wirth Acquires Additional Shares of InnSuites Hospitality Trust (IHT) (GuruFocus.com)
Feb-15-24 06:50AM The 7 Best REITs to Buy in February 2024 (InvestorPlace)
Jan-08-24 06:25AM IHT DECLARES 54TH CONSECUTIVE ANNUAL DIVIDEND AS REVENUES CONTINUE TO CLIMB WITH RECORD DECEMBER (GlobeNewswire)
Dec-29-23 11:01PM InnSuites Hospitality Trust Chairman James Wirth Acquires 1,500 Shares (GuruFocus.com) +10.46%
Dec-23-23 01:01PM Chairman James Wirth Acquires 2,000 Shares of InnSuites Hospitality Trust (IHT) (GuruFocus.com)
Dec-07-23 04:52PM IHT THIRD FISCAL QUARTER REVENUES INCREASE 7% (GlobeNewswire)
Nov-30-23 03:04PM Insider Buying: Chairman James Wirth Acquires Shares of InnSuites Hospitality Trust (IHT) (GuruFocus.com)
DJT - Trump Media & Technology Group Corp. - Stock Price Chart
TickerDJT [NASD]
CompanyTrump Media & Technology Group Corp.
CountryUSA
IndustryInternet Content & Information
Market Cap6.17BEPS (ttm)-0.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.85EPS Q/Q65.97%
Dividend-Sales Q/Q-
Insider Own71.39%Inst Own1.26%
Insider Trans0.00%Inst Trans4.62%
Short Float11.73%Earnings-
Analyst Recom-Target Price-
Avg Volume6.38M52W Range12.40 - 79.38
Today 03:30PM DJT Stock Earns Donald Trump Another $1.8 Billion Payout (InvestorPlace) -9.61%
08:02AM The Trump Media stock rebound has picked up steam during Donald Trump's criminal trial (Quartz)
06:10AM Trump Media Stock Analysis: Why I Wouldn't Touch DJT With a 10-Foot Pole (InvestorPlace)
Apr-30-24 01:36PM DJT Stock Alert: Why This Analyst Says You Should Sell Trump Media Right Now (InvestorPlace) +6.94%
Apr-29-24 11:50AM 13 Most Popular Retail Investor Stocks in 2024 (Insider Monkey) +12.40%
06:00AM Trump Media Provides Additional Information to DJT Investors Regarding Recalling Shares (GlobeNewswire)
Apr-27-24 09:00AM Musk passes Zuckerberg, Trump gets more, Jamie Dimon's 'booming' economy: Leadership news roundup (Quartz)
Apr-26-24 01:21PM Meme stocks are 'speculation,' not investing. Here's why. (Yahoo Finance Video) +7.92%
11:29AM Trump Media Stock's Wild Ride: Should You Jump on Board or Steer Clear? (InvestorPlace)
05:00AM Trump Media's roller-coaster first-month, from 'meme stock' highs to bruising lows (Quartz)
FBLG - FibroBiologics Inc - Stock Price Chart
TickerFBLG [NASD]
CompanyFibroBiologics Inc
CountryUSA
IndustryBiotechnology
Market Cap259.47MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B178.68EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own18.87%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume96.76K52W Range6.53 - 55.00
Apr-25-24 08:00AM FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids (GlobeNewswire)
Apr-11-24 09:31AM FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office (GlobeNewswire)
Apr-04-24 09:31AM FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA (GlobeNewswire)
Mar-28-24 09:31AM FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus (GlobeNewswire) -8.00%
Mar-19-24 09:31AM FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment (PR Newswire) +21.36%
Mar-13-24 09:31AM FibroBiologics to Present at Advanced Wound Care Summit USA (PR Newswire) -5.83%
Mar-06-24 09:31AM FibroBiologics Appoints Ruben A. Garcia as General Counsel (PR Newswire)
Feb-29-24 05:44PM FibroBiologics Files 2023 Form 10-K Annual Report (PR Newswire)
Feb-20-24 09:31AM FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum (PR Newswire) -8.52%
Feb-13-24 09:31AM FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases (PR Newswire) +88.38%
BDRX - Biodexa Pharmaceuticals Plc ADR - Stock Price Chart
TickerBDRX [NASD]
CompanyBiodexa Pharmaceuticals Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap0.32MEPS (ttm)-19.22
P/E-EPS this Y91.79%
Forward P/E-EPS next Y15.41%
PEG-EPS past 5Y86.34%
P/S0.67EPS next 5Y-
P/B3.46EPS Q/Q99.66%
Dividend-Sales Q/Q-61.66%
Insider Own-Inst Own42.90%
Insider Trans-Inst Trans-10.06%
Short Float-EarningsApr 19/b
Analyst Recom1.00Target Price8.00
Avg Volume3.30M52W Range0.67 - 20.80
Apr-30-24 11:52AM Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting (GlobeNewswire) +15.27%
Apr-28-24 12:01PM 12 ChatGPT Penny Stock Picks Right Now (Insider Monkey)
Apr-26-24 03:18PM Why Is Biodexa (BDRX) Up 70% Today? (InvestorPlace) +79.36%
08:30AM Biodexa Enters Into Exclusive License to eRapa , a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) (GlobeNewswire)
Apr-19-24 08:00AM Preliminary Results for the Year Ended 31 December 2023 (GlobeNewswire) -8.30%
Mar-28-24 11:22AM Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today? (InvestorPlace) +88.59%
08:15AM Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers (ACCESSWIRE)
Mar-01-24 08:00AM Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone (ACCESSWIRE) +7.09%
Feb-23-24 08:30AM Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update (GlobeNewswire)
Feb-08-24 08:30AM Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients (GlobeNewswire)
1234567891011⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.